The Federal government sequester, the automatic spending cuts into both defense and non-defense categories that began in March of 2013, has ended, at least for the time being. Over the past few weeks, Congress put together House Resolution (H.R.) 3547, named the Consolidated Appropriations Act of 2014. H.R. 3547 is an omnibus bill, a bill […]
Accelerating diagnosis, treatments, and a cure for celiac disease and non-celiac gluten sensitivity through research, education, and advocacy.
Because of your will and generous support, CDF is beginning to move the diagnosis needle for celiac disease and gluten sensitivity. We have seen progress through our efforts in Research, Education, Advocacy and Awareness. Please take a look at our “Year in Review” to see the impact your support has made.
Celiac Disease Foundation (CDF) launched the nation’s most comprehensive online directory for patients to find reliable information on healthcare practitioners familiar with diagnosing and treating celiac disease and other gluten-related disorders. From coast to coast, patients can search by ZIP code to help them choose a healthcare practitioner in their town who will understand their […]
For more than 20 years, Celiac Disease Foundation has been the trusted source for the dissemination of evidence-based research regarding celiac disease. CEO Marilyn G. Geller challenges the science behind a controversial new report alleging that genetically engineered foods could be an environmental trigger for celiac disease and gluten sensitivity.
FDA clarifies what the Gluten-Free Labeling Rule means for restaurants – considers enforcement action to protect consumers
Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, today announced that the first randomized study patient was dosed in the CeliAction Study™